Posted inClinical Updates Neurology
Plasma N-Terminal Tau as a Biomarker for Cognitive Decline and Neurodegeneration in Alzheimer’s Disease: Insights from the ADNI Cohort
Elevated plasma N-terminal tau (NT1) levels correlate with amyloid-dependent cognitive decline, hippocampal atrophy, and neurodegeneration, offering a promising minimally invasive biomarker for Alzheimer’s disease risk assessment and disease progression monitoring.
